Ningetinib

Ningetinib Suppliers list
Company Name: ChemShuttle, Inc.  
Tel: 0510-83588313-811 18800520310
Email: sales@chemshuttle.com
Company Name: BOC Sciences  
Tel: 1-631-485-4226; 16314854226
Email: info@bocsci.com
Company Name: Shanghai Topbiochem Technology Co., Ltd  
Tel: 021-58170097
Email: info@topbiochem.com
Company Name: ShangHai Caerulum Pharma Discovery Co., Ltd.  
Tel: 18149758185 18149758185
Email: sales-cpd@caerulumpharma.com
Company Name: Shanghai Lollane Biological Technology Co.,Ltd.  
Tel: 021-52996696,15000506266 15000506266
Email:

Ningetinib manufacturers

  • Ningetinib
  • Ningetinib pictures
  • $35.00
  • 2026-07-27
  • CAS:1394820-69-9
  • Purity: 99.98%
  • Supply Ability: 10g
Ningetinib Basic information
Product Name:Ningetinib
Synonyms:CS-2653;Ningetinib-Tosylate(free base);Ningetinib;Ningetinib(free base);CT053PTSA;1H-Pyrazole-4-carboxamide, N-[3-fluoro-4-[[7-(2-hydroxy-2-methylpropoxy)-4-quinolinyl]oxy]phenyl]-2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-;N-(3-fluoro-4-((7-(2-hydroxy-2-methylpropoxy)quinolin-4-yl)oxy)phenyl)-1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide;Vascular endothelial growth factor receptor,inhibit,c-Met/HGFR,TAM Receptor,Mer,Tyro3,VEGFR,Ningetinib,Axl,Inhibitor
CAS:1394820-69-9
MF:C31H29FN4O5
MW:556.58
EINECS:
Product Categories:
Mol File:1394820-69-9.mol
Ningetinib Structure
Ningetinib Chemical Properties
density 1.348±0.06 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMF: 15 mg/ml; DMF:PBS (pH 7.2) (1:5): 0.16 mg/ml; DMSO: 2 mg/ml
form A crystalline solid
pka11.00±0.70(Predicted)
color White to off-white
Safety Information
MSDS Information
Ningetinib Usage And Synthesis
UsesNingetinib, is a potent, orally bioavailable small molecule tyrosine kinase inhibitor (TKI) with IC50s of 6.7, 1.9 and <1.0 nM for c-Met, VEGFR2 and Axl, respectively.
in vivo

When single dosed orally (3 mg/kg) to U87MG tumor-bearing nude mice, Ningetinib (CT053PTSA) potently inhibits the phosphorylation of c-Met and its downstream signaling kinases AKT and ERK1/2 for up to 6 hours in tumor tissues. In orthotopic U87MG human glioblastoma xenograft model, Ningetinib prolongs the median survival time (MST) and yields significant increase in life-span value (ILS=32%, p=0.003) at an oral dose of 20 mg/kg/day (dosed 21 days) versus the vehicle-treated group[1].

IC 50VEGFR2: 1.9 nM (IC50); Axl
Ningetinib Preparation Products And Raw materials
Tag:Ningetinib(1394820-69-9) Related Product Information
N-[4-[(2-Amino-3-chloropyridin-4-yl)oxy]-3-fluorophenyl]-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide 2,4-Thiazolidinedione, 3-[[(3Z)-2,3-dihydro-3-[[4-(4-MorpholinylMethyl)-1H-pyrrol-2- yl]Methylene]-2-oxo-1H-indol-5-yl]Methyl]-, hydrochloride Cabozantinib LY2801653 1,1-Cyclopropanedicarboxamide, N-(4-fluorophenyl)-N'-[4-[[7-methoxy-6-[(methylamino)carbonyl]-4-quinolinyl]oxy]phenyl]- AXL Protein, HUMAN (BIOTINYLATED, HEK293, HIS-AVI)